Citations (53)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Ewa Lundgren. (1999) Primary Hyperparathyroidism of Postmenopausal Women. Upsala Journal of Medical Sciences 104:2, pages 87-130.
Read now
Read now
L. Lind, B. Wengle, H. Lithell & S. Ljunghall. (1991) Reduction in Serum Alkaline Phosphatase Levels by Treatment with Active Vitamin D (Alphacalcidol) in Primary and Secondary Hyperparathyroidism and in Euparathyroid Individuals. Scandinavian Journal of Urology and Nephrology 25:3, pages 233-236.
Read now
Read now
Articles from other publishers (51)
Seung-Kwon Myung & Heram Cho. (2023) Effects of intermittent or single high-dose vitamin D supplementation on risk of falls and fractures: a systematic review and meta-analysis. Osteoporosis International 34:8, pages 1355-1367.
Crossref
Crossref
Katherine A. Cironi, Peter P. Issa, Aaron L. Albuck, Christina McCarthy, Leely Rezvani, Mohammad Hussein, Xinyi Luo, Mohamed Shama, Eman Toraih & Emad Kandil. (2023) Comparison of Medical Management versus Parathyroidectomy in Patients with Mild Primary Hyperparathyroidism: A Meta-Analysis. Cancers 15:12, pages 3085.
Crossref
Crossref
H. Ejlsmark-Svensson, L. Rolighed, T. Harsløf & L. Rejnmark. (2021) Risk of fractures in primary hyperparathyroidism: a systematic review and meta-analysis. Osteoporosis International 32:6, pages 1053-1060.
Crossref
Crossref
Niya Narayanan, Rajan Palui, Chandhana Merugu, Sitanshu Sekhar Kar, Sadishkumar Kamalanathan, Jayaprakash Sahoo, Sandhiya Selvarajan & Dukhabandhu Naik. (2021) The Risk of Fractures in Primary Hyperparathyroidism: A Meta‐Analysis. JBMR Plus 5:4.
Crossref
Crossref
Lars Rejnmark & Henriette Ejlsmark-Svensson. (2020) Effects of PTH and PTH Hypersecretion on Bone: a Clinical Perspective. Current Osteoporosis Reports 18:3, pages 103-114.
Crossref
Crossref
Huai H. Loh, Anne Yee & Huai S. Loh. (2020) Bone health among patients with primary aldosteronism: a systematic review and meta-analysis. Minerva Endocrinologica 44:4.
Crossref
Crossref
Luis Gracia-Marco, Beatriz García-Fontana, Esther Ubago-Guisado, Dimitris Vlachopoulos, Antonia García-Martín & Manuel Muñoz-Torres. (2020) Analysis of Bone Impairment by 3D DXA Hip Measures in Patients With Primary Hyperparathyroidism: A Pilot Study. The Journal of Clinical Endocrinology & Metabolism 105:1, pages 175-184.
Crossref
Crossref
Pedro Rozas Moreno & Antonia Garc?a Mart?n. 2014. El hueso en las enfermedades endocrinas y nutricionales. El hueso en las enfermedades endocrinas y nutricionales
111
126
.
Stinus Hansen, Jens-Erik Beck Jensen, Lars Rasmussen, Ellen M Hauge & Kim Brixen. (2010) Effects on bone geometry, density, and microarchitecture in the distal radius but not the tibia in women with primary hyperparathyroidism: A case-control study using HR-pQCT. Journal of Bone and Mineral Research 25:9, pages 1941-1947.
Crossref
Crossref
Nathan A. Merriman, Mary E. Putt, David C. Metz & Yu–Xiao Yang. (2010) Hip Fracture Risk in Patients With a Diagnosis of Pernicious Anemia. Gastroenterology 138:4, pages 1330-1337.
Crossref
Crossref
Claudio Marcocci, Luisella Cianferotti, Shonni J. Silverberg & John P. Bilezikian. 2010. Osteoporosis in Men. Osteoporosis in Men
465
478
.
Edda Vignali, Giuseppe Viccica, Daniele Diacinti, Filomena Cetani, Luisella Cianferotti, Elena Ambrogini, Chiara Banti, Romano Del Fiacco, John P. Bilezikian, Aldo Pinchera & Claudio Marcocci. (2009) Morphometric Vertebral Fractures in Postmenopausal Women with Primary Hyperparathyroidism. The Journal of Clinical Endocrinology & Metabolism 94:7, pages 2306-2312.
Crossref
Crossref
William D Fraser. (2009) Hyperparathyroidism. The Lancet 374:9684, pages 145-158.
Crossref
Crossref
Leif Mosekilde. (2008) Primary hyperparathyroidism and the skeleton. Clinical Endocrinology 69:1, pages 1-19.
Crossref
Crossref
Kristin Wagner & Judiann Miskulin. (2007) Effect of parathyroidectomy on osteoporosis and bone metabolism. Clinical Reviews in Bone and Mineral Metabolism 5:2, pages 115-121.
Crossref
Crossref
I-Te Lee, Wayne Huey-Herng Sheu, Shih-Te Tu, Shi-Wen Kuo & Dee Pei. (2006) Bisphosphonate pretreatment attenuates hungry bone syndrome postoperatively in subjects with primary hyperparathyroidism. Journal of Bone and Mineral Metabolism 24:3, pages 255-258.
Crossref
Crossref
Christine Chappard, Christian Roux, Pascal Laugier, Michel Paillard & Pascal Houillier. (2006) Statut osseux au cours de l'hyperparathyroïdie primitive mesurée par densité minérale osseuse régionale par densitométrie corps entier et ultrasonographie quantitative au calcanéum. Revue du Rhumatisme 73:1, pages 83-92.
Crossref
Crossref
Christine Chappard, Christian Roux, Pascal Laugier, Michel Paillard & Pascal Houillier. (2006) Bone status in primary hyperparathyroidism assessed by regional bone mineral density from the whole body scan and QUS imaging at calcaneus. Joint Bone Spine 73:1, pages 86-94.
Crossref
Crossref
Catherine Cormier. (2006) Hyperparathyroïdie. EMC - Appareil locomoteur 1:1, pages 1-14.
Crossref
Crossref
Nidal A. Younes, Yanal Shafagoj, Faisal Khatib & Mahmoud Ababneh. (2005) Laboratory screening for hyperparathyroidism. Clinica Chimica Acta 353:1-2, pages 1-12.
Crossref
Crossref
Sutada Lotinun, Glenda L Evans, James T Bronk, Mark E Bolander, Thomas J Wronski, Erik L Ritman & Russell T Turner. (2004) Continuous Parathyroid Hormone Induces Cortical Porosity in the Rat: Effects on Bone Turnover and Mechanical Properties. Journal of Bone and Mineral Research 19:7, pages 1165-1171.
Crossref
Crossref
Carolyn Becker. (2003) Clinical evaluation for osteoporosis. Clinics in Geriatric Medicine 19:2, pages 299-320.
Crossref
Crossref
Ellen M. Hauge, Torben Steiniche & Troels T. Andreassen. 2003. Handbook of Histology Methods for Bone and Cartilage. Handbook of Histology Methods for Bone and Cartilage
391
410
.
M. Davies, W. D. Fraser & D. J. Hosking. (2002) The management of primary hyperparathyroidism. Clinical Endocrinology 57:2, pages 145-155.
Crossref
Crossref
Lorraine A. Fitzpatrick. (2002) Secondary Causes of Osteoporosis. Mayo Clinic Proceedings 77:5, pages 453-468.
Crossref
Crossref
Christine Chappard, Pascal Houillier & Michel Paillard. (2001) Bone status in primary hyperparathyroidism. Joint Bone Spine 68:2, pages 112-119.
Crossref
Crossref
Christine Chappard, Pascal Houillier & Michel Paillard. (2001) Statut osseux dans l’hyperparathyroïdie primitive. Revue du Rhumatisme 68:3, pages 210-218.
Crossref
Crossref
Yener N. Yeni, Deepak Vashishth & David P. Fyhrie. (2001) Estimation of Bone Matrix Apparent Stiffness Variation Caused by Osteocyte Lacunar Size and Density. Journal of Biomechanical Engineering 123:1, pages 10-17.
Crossref
Crossref
D. Sudhaker Rao. (2014) Parathyroidectomy for asymptomatic primary hyperparathyroidism (PHPT): Is it worth the risk?. Journal of Endocrinological Investigation 24:2, pages 131-134.
Crossref
Crossref
Maurizio Rossini, Davide Gatti, Giancarlo Isaia, Leonardo Sartori, Vania Braga & Silvano Adami. (2001) Effects of Oral Alendronate in Elderly Patients with Osteoporosis and Mild Primary Hyperparathyroidism. Journal of Bone and Mineral Research 16:1, pages 113-119.
Crossref
Crossref
AMBRISH MITHAL, FRANCISCO BANDEIRA, XUNWU MENG, SHONNI J. SILVERBERG, YIFAN SHI, SAROJ K. MISHRA, LUIZ GRIZ, GEISA MACEDO, GUSTAV CELDAS, CRISTINA BANDEIRA, JOHN P. BILEZIKIAN & D. SUDHAKER RAO. 2001. The Parathyroids. The Parathyroids
375
xiii
.
Zeba Syed & Aliya Khan. (2000) Skeletal Effects of Primary Hyperparathyroidism. Endocrine Practice 6:5, pages 385-388.
Crossref
Crossref
Catherine Cormier, Jean-Claude Souberbielle & Catherine Kindermans. (2000) Hyperparathyroidism: the limits of surgery in cases of bone or cardiovascular involvement. Current Opinion in Rheumatology 12:4, pages 349-353.
Crossref
Crossref
C. Cormier. (2000) Hiperparatiroidismo. EMC - Aparato Locomotor 33:4, pages 1-15.
Crossref
Crossref
Sundeep Khosla, L. Joseph MeltonIIIIII, Robert A. Wermers, Cynthia S. Crowson, W. Michael O'Fallon & B. Lawrence Riggs. (1999) Primary Hyperparathyroidism and the Risk of Fracture: A Population-Based Study. Journal of Bone and Mineral Research 14:10, pages 1700-1707.
Crossref
Crossref
Kristine D. Harper & Thomas J. Weber. (1998) SECONDARY OSTEOPOROSIS. Endocrinology and Metabolism Clinics of North America 27:2, pages 325-348.
Crossref
Crossref
S Adami, V Braga, R Squaranti, M Rossini, D Gatti & N Zamberlan. (1998) Bone Measurements in Asymptomatic Primary Hyperparathyroidism. Bone 22:5, pages 565-570.
Crossref
Crossref
Robert A WermersMDMD, Sundeep KhoslaMDMD, Elizabeth J AtkinsonMSMS, Clive S GrantMDMD, Stephen F HodgsonMDMD, W.Michael O’FallonPhDPhD & L.Joseph MeltonIII, MDIII, MD. (1998) Survival after the Diagnosis of Hyperparathyroidism: A Population-based Study11Access the “Journal Club” discussion of this paper at: http://www.elsevier.com/locate/ajmselect/. The American Journal of Medicine 104:2, pages 115-122.
Crossref
Crossref
Kim Thorsen, Anders O Kristoffersson & Ronny P Lorentzon. (1997) Changes in bone mass and serum markers of bone metabolism after parathyroidectomy. Surgery 122:5, pages 882-887.
Crossref
Crossref
P. Christiansen, T. Steiniche, K. Brixen, I. Hessov, F. Melsen, P. Charles & Le. Mosekilde. (1997) Primary hyperparathyroidism: Biochemical markers and bone mineral density at multiple skeletal sites in Danish patients. Bone 21:1, pages 93-99.
Crossref
Crossref
Andrew B. Grey. (1997) The skeletal effects of primary hyperparathyroidism. Baillière's Clinical Endocrinology and Metabolism 11:1, pages 101-116.
Crossref
Crossref
Shonni J. Silverberg. 1997. Endocrine Neoplasms. Endocrine Neoplasms
163
181
.
Torben Steiniche. (2011) Bone histomorphometry in the pathophysiological evaluation of primary and secondary osteoporosis and various treatment modalities. APMIS 103:S51, pages 5-44.
Crossref
Crossref
H. Brockstedt, P. Christiansen, L. Mosekilde & F. Melsen. (1995) Reconstruction of cortical bone remodeling in untreated primary hyperparathyroidism and following surgery. Bone 16:1, pages 109-117.
Crossref
Crossref
Karin Larsson, S. LJUNGHALL, U. B. KRUSEMO, T. NÆSSÉN, E. LINDH & I. PERSSON. (2009) The risk of hip fractures in patients with primary hyperparathyroidism: a population‐based cohort study with a follow‐up of 19 years. Journal of Internal Medicine 234:6, pages 585-593.
Crossref
Crossref
P. Christiansen, T. Steiniche, H. Brockstedt, L. Mosekilde, I. Hessov & F. Melsen. (1993) Primary hyperparathyroidism: Iliac crest cortical thickness, structure, and remodeling evaluated by histomorphometric methods. Bone 14:5, pages 755-762.
Crossref
Crossref
Gregory R. Mundy & T. John MartinM. Peacock. 1993. Physiology and Pharmacology of Bone. Physiology and Pharmacology of Bone
443
483
.
E. Lindh, S. LJUNGHALL, K. LARSSON & B. LAVÖ. (2009) Screening for antibodies against gliadin in patients with osteoporosis. Journal of Internal Medicine 231:4, pages 403-406.
Crossref
Crossref
Sverker Ljunghall, Per Hellman, Jonas Rastad & Göran Åkerström. (1991) Primary hyperparathyroidism: Epidemiology, diagnosis and clinical picture. World Journal of Surgery 15:6, pages 681-687.
Crossref
Crossref
Susan M. Ott. (2009) Methods of determining bone mass. Journal of Bone and Mineral Research 6:S2, pages S71-S76.
Crossref
Crossref
Hunter HeathIIIIII. (2009) Clinical spectrum of primary hyperparathyroidism: Evolution with changes in medical practice and technology. Journal of Bone and Mineral Research 6:S2, pages S63-S70.
Crossref
Crossref